Amneal Pharmaceuticals, Inc. (AMRX) › Total AssetsAmneal Pharmaceuticals, Inc. (AMRX) — Total AssetsAnnual figures by period end, from SEC filings.2017-12-31: $1.34B2018-12-31: $4.35B2019-12-31: $3.67B2020-12-31: $4.01B2021-12-31: $3.94B2022-12-31: $3.80B2023-12-31: $3.47B2024-12-31: $3.50B2025-12-31: $3.68B$3.68B2017-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$3.68B+5.1%2026-02-27Balance as of period end2024-12-31$3.50B+0.8%2026-02-27Balance as of period end2023-12-31$3.47B-8.6%2025-02-28Balance as of period end2022-12-31$3.80B-3.6%2024-03-14Balance as of period end2021-12-31$3.94B-1.7%2023-03-03Balance as of period end2020-12-31$4.01B+9.3%2022-03-01Balance as of period end2019-12-31$3.67B-15.8%2021-03-01Balance as of period end2018-12-31$4.35B+224.4%2020-03-02Balance as of period end2017-12-31$1.34B—2019-03-01Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)